Abstract
High risk of recurrence after CR gives the reasonable weight to adjuvant therapy for DBDC. However, when LN metastasis absent, the role of adjuvant chemotherapy after surgery is still controversial. Thus, we aimed to analyze risk factors for recurrence of DBDC without LN metastasis after CR and identify high-risk groups, which would be the candidates for adjuvant chemotherapy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
